Now that it’s harder to get decongestants containing pseudoephedrine, will cold and allergy sufferers have to make do with weaker over-the-counter drugs?
That depends. As of Sept. 30, the effective date of an amendment to the U.S. Patriot Act, nasal products containing pseudoephedrine must be sold “behind the counter,” which means the purchaser has to show […]
Schering-Plough`s third quarter earnings beat Wall Street`s expectations, and analysts expect the company to continue the strong performance based in large part on its cholesterol-lowering drugs Vytorin and Zetia.
Schering-Plough said its net income jumped to $287 million from $43 million in the year-ago quarter, a more than six-fold increase.
Net sales of its cholesterol joint venture […]
Schering-Plough’s third quarter earnings beat Wall Street’s expectations, and analysts expect the company to continue the strong performance based in large part on its cholesterol-lowering drugs Vytorin and Zetia.
Schering-Plough said its net income jumped to $287 million from $43 million in the year-ago quarter, a more than six-fold increase.
Net sales of its cholesterol joint venture […]
October 20, 2006 — Nasonex® (mometasone furoate monohydrate), the number one doctor-prescribed nasal spray in Canada for the treatment of allergic rhinitis (seasonal and perennial nasal allergies) and acute sinusitis as an adjunctive treatment to antibiotics is now scent-free.
Scent-free Nasonex was developed in direct response to the preferences of allergy patients. In an Internet survey […]
It could be a tough fall allergy season, and not just because of the ragweed count. Another problem, say some experts, is an ingredient many drug companies have begun putting in nonprescription decongestants in place of pseudoephedrine.
The active ingredient in Sudafed and other oral decongestants, pseudoephedrine will be subject to new federal sales restrictions starting […]